Danny Juan Avalos

Danny Juan Avalos

Auto-generated profile, based on publicly available information

Danny Juan Avalos

Gastroenterology, Miami Gastro LLC, Homestead, Florida, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
NNNiharika Nalagatla
Niharika Nalagatla
KFKatherine Falloon
Katherine Falloon
GTGloria Tran
Gloria Tran
NBNienke Z. Borren
Nienke Z. Borren
DADanny Avalos
Danny Avalos
AAAshwin N. Ananthakrishnan
Ashwin N. Ananthakrishnan

1 September 2018 in Clinical and Experimental Gastroenterology
Verified
Journal Article
Open access
PDF file
DADanny J Avalos
Danny J Avalos
ISIrene Sarosiek
Irene Sarosiek
PLPriyadarshini Loganathan
Priyadarshini Loganathan
Richard MccallumRichard Mccallum
Richard Mccallum
Diabetic gastroparesis (DMGP) is a condition of delayed gastric emptying after gastric outlet obstruction has been excluded. Symptoms of nausea, vomiting, early satiety, bloating, and abdominal pain are associated with DMGP. Uncontrolled symptoms can lead to overall poor quality of life and financial burdens on the healthcare system. A combination of antiemetics and prokinetics is used in symptom control; metoclopramide is the main prokinetic available for clinical use and is the only U.S. Food and Drug Administration-approved agent in the United States. However, a black box warning in 2009 reporting its association with tardive dyskinesia and recommending caution in chronically using this agent beyond 3 months has decreased its role in clinical practice. There is an unmet need for new prokinetics with good efficacy and safety profiles. Currently, there are several new drugs with different mechanisms of action in the pipeline that are under investigation and show promising preliminary results. Surgically combining gastric electrical stimulation with pyloroplasty is considered “gold” standard. Advances in therapeutic endoscopic intervention with gastric per-oral endoscopic pyloromyotomy have also been shown to improve gastric emptying and gastroparesis (GP) symptoms. In this review, we will comment on the challenges encountered when managing patients with DMGP and provide an update on advances in drug development and endoscopic and surgical interventions.

7 July 2018 in Digestive Diseases and Sciences
Verified
Journal Article
Open access
PDF file
ODOriana M. Damas
Oriana M. Damas
DEDerek Estes
Derek Estes
DADanny Avalos
Danny Avalos
MQMaria A. Quintero
Maria A. Quintero
DMDiana Morillo
Diana Morillo
SSSeth J. Schwartz
Seth J. Schwartz
Introduction The incidence of inflammatory bowel disease (IBD) among US Hispanics is rising. Adoption of an American diet and/or US acculturation may help explain this rise. Aims To measure changes in diet occurring with immigration to the USA in IBD patients and controls, and to compare US acculturation between Hispanics with versus without IBD. Last, we examine the current diet of Hispanics with IBD compared to the diet of Hispanic controls. Methods This was a cross-sectional study of Hispanic immigrants with and without IBD. Participants were recruited from a university-based GI clinic. All participants completed an abbreviated version of the Stephenson Multi-Group Acculturation Scale and a 24-h diet recall (the ASA-24). Diet quality was calculated using the Healthy Eating Index (HEI-2010). Results We included 58 participants: 29 controls and 29 IBD patients. Most participants were Cuban or Colombian. Most participants, particularly those with IBD, reported changing their diet after immigration (72% of IBD and 57% of controls). IBD participants and controls scored similarly on US and Hispanic acculturation measures. IBD patients and controls scored equally poorly on the HEI-2010, although they differed on specific measures of poor intake. IBD patients reported a higher intake of refined grains and lower consumption of fruits, whereas controls reported higher intake of empty calories (derived from fat and alcohol). Conclusion The majority of Hispanics change their diet upon immigration to the USA and eat poorly irrespective of the presence of IBD. Future studies should examine gene–diet interactions to better understand underlying causes of IBD in Hispanics.

29 March 2018 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
DADanny J. Avalos
Danny J. Avalos
AMAntonio Mendoza-Ladd
Antonio Mendoza-Ladd
MZMarc J. Zuckerman
Marc J. Zuckerman
MBMohammad Bashashati
Mohammad Bashashati
AAAndres Alvarado
Andres Alvarado
ODOriana M. Damas
Oriana M. Damas

1 April 2022 in Journal of Investigative Medicine
Verified
Journal Article
Closed access
PDF file
DADanny Juan Avalos
Danny Juan Avalos
JSJinendra Satiya
Jinendra Satiya
ACAlberto Contreras
Alberto Contreras
STShivani Trivedi
Shivani Trivedi
LALuis Alvarado
Luis Alvarado
MZMarc J. Zuckerman
Marc J. Zuckerman
Latin America has experienced a rise in the prevalence and incidence of inflammatory bowel disease (IBD). Differences in IBD phenotype between Hispanics in Latin America and those in the USA have not been described. We conducted a systematic review with meta-analysis of population-based and cohort studies comparing the phenotype of ulcerative colitis (UC) and Crohn's disease (CD) in Latin Americans and US Hispanics. A systematic search was conducted up to March 2019 using MEDLINE, EMBASE and Google Scholar. Inclusion criterion includes studies describing IBD phenotype in Latin Americans or in US Hispanics. Exclusion criterion includes prevalence or incidence studies not describing phenotype. A random effects model was chosen “a priori” for analysis of pooled proportions. A total of 46 studies were included from Latin America and 7 studies from the USA. The predominant IBD subtype in Latin America was UC with a more balanced UC:CD ratio noted in Puerto Rico (0.53) and Brazil (0.56). UC-related extensive colitis was more common in US Hispanics (0.64) than in Latin Americans (0.38), p<0.001. CD phenotype was similar between US Hispanics and Latin Americans. UC is the predominant IBD subtype in Latin America, with the exception of Puerto Rico and Brazil which demonstrate a more balanced UC:CD ratio. In UC, extensive colitis was more frequently seen in US Hispanics than in Latin Americans. CD phenotype was similar in both US Hispanics and Latin Americans.